about
Correlation between ELISA and pseudovirion-based neutralisation assay for detecting antibodies against human papillomavirus acquired by natural infection or by vaccinationSafety of an Escherichia coli-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine: an open-label phase I clinical trial.The development of a recombinant hepatitis E vaccine HEV 239.Long-term efficacy of a hepatitis E vaccine.Epidemiology of zoonotic hepatitis E: a community-based surveillance study in a rural population in ChinaA valuable antigen detection method for diagnosis of acute hepatitis E.Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy.Development of the hepatitis E vaccine: from bench to field.Prophylaxis against hepatitis E: at risk populations and human vaccines.Putative receptor-binding sites of hepatitis E virus.Characterization of an Escherichia coli-derived human papillomavirus type 16 and 18 bivalent vaccine.Hydrophobicity of reactive site loop of SCCA1 affects its binding to hepatitis B virusPersistence of antibodies acquired by natural hepatitis E virus infection and effects of vaccination.Modeling the long-term antibody response of a hepatitis E vaccine.Immunogenicity and safety of an E. coli-produced bivalent human papillomavirus (type 16 and 18) vaccine: A randomized controlled phase 2 clinical trial.Rationally respond to post-vaccination adverse events.Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity.Classification of human and zoonotic group hepatitis E virus (HEV) using antigen detection.[Hydrophobicity of reactive site loop of SCCA1 affects its binding to HBV].Cytomegalovirus shedding in healthy seropositive female college students: a six-month longitudinal study.The prevalence and concordance of human papillomavirus infection in different anogenital sites among men and women in Liuzhou, China: A population-based study.[Mammalian gene-transfer and expression efficiencies of baculovirus bacV-CMV-EGFPA].[Rapid and efficient expression of foreign genes in mammalian cells by baculovirus vectors].Hepatitis E vaccine development: a 14 year odyssey.Sex differences in the incidence and clearance of anal human papillomavirus infection among heterosexual men and women in Liuzhou, China: An observational cohort studyHepatitis E vaccine candidate harboring a non-particulate immunogen of E2 fused with CRM197 fragment A
P50
Q34033823-F5E51404-6725-4207-ACCE-B2EEF5BF3DEAQ34290684-A96136EF-00BD-41FC-A3FA-04A441FC817FQ34464464-15C4BE08-D183-47B2-AC45-6655B27A5F8BQ34465637-C42352A5-CAC0-4EF5-BE52-2E5D19675E61Q35086897-8142C930-5AF8-4BB6-B043-797C3374080EQ35331616-5EC044A3-16AF-4043-A71F-708E5DCD4936Q36973372-E5E573B1-B079-4FB8-91C4-F8543A37179BQ38096975-FC14E65C-BD43-4787-AD6C-41EBA9BE6A56Q38699244-BB238B1D-28F3-4CB5-9098-FD2C6567E6A6Q40033753-9F39A253-3FE5-45C9-8FCF-7F2D53380062Q40111455-EB393125-1C8F-4D8D-9B85-86B685333760Q40420517-E6DEE05D-3381-4749-8BB8-1F7C6EE99003Q40455221-17823576-D546-43AB-9A11-08F7BCCBF7BBQ40781273-8CE7586F-4DB1-4F01-AC53-1B6CF12FA362Q41145359-FB66EC7D-7E20-4A65-A644-8C475B9A6ACFQ42228471-73A5DB63-DEB6-4611-A3A8-DEAE45A20546Q42244598-679D5D5F-E614-47C5-84B5-4A525C38482CQ43168143-F5F4D32E-7E39-49AE-9FE6-0568C4CC9A4FQ46462086-D65B4754-AB9E-4079-928E-4B9B2107E792Q47558672-F81231D4-5C34-4125-8687-B811903C2A32Q47732248-8C71D561-4F12-4A4E-99AF-DD9417796766Q50758056-5EE4A268-486E-47CF-8FD8-9C4247858B22Q50764125-CCAAF09A-EE88-42E7-9CB1-D89DCF8AC617Q54334450-EFB8FB1D-198D-47D9-A0D9-416CE7A424D6Q64128093-67B3CD66-C5DF-44A3-AE6C-268F3459701DQ91891693-960FFCBA-5787-4845-B1B4-F95B3C29A95F
P50
description
investigador
@es
researcher
@en
name
Ting Wu
@en
type
label
Ting Wu
@en
prefLabel
Ting Wu
@en
P31
P496
0000-0002-1806-3056